Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: BigKNY3 who wrote (18115)	1/25/1999 8:10:00 AM
From: VLAD	Read Replies (4) \| Respond to of 23519

Kahuna, What's the relevance to Vivus? Did you really mean to post this? Message 7463539 To me this demonstrates the importance that Vivus needs to turn Japan MUSE rights over to a big pharma ASAP. 25 months after MUSE launching in the USA Vivus has made ZERO progress in the world's second largest pharmaceutical market. Pfizer on the other hand has things all wraped up in Japan only 10 months after Viagra's USA launch. Sure I know that Vivus is a small biotech company but it seems to me like they had tons of time to at least show some direction concerning Japan and they never moved a finger.